Extracorporeal circuit


Also found in: Dictionary, Thesaurus, Encyclopedia, Wikipedia.
Related to Extracorporeal circuit: extracorporeal circulation

Extracorporeal circuit (ECC)

The path the hemodialysis patient's blood takes outside of the body. It typically consists of plastic tubing, a hemodialysis machine, and a dialyzer.
Mentioned in: Dialysis, Kidney
References in periodicals archive ?
Coating of extracorporeal circuit with heparin does not prevent sequestration of propofol in vitro.
In the event that the cost of argatroban is an issue, as it was with this case, the patient would be converted to conventional HHD utilizing HDF to hopefully prevent extracorporeal circuit from clotting.
Predilution, citrate-based substitution fluid provides both anticoagulation within the extracorporeal circuit and control of add-base balance in critically ill patients at risk of bleeding in acute renal failure I t is easy to apply and safe Clearance can be varied as long as a constant ratio between blood and substitution flow is maintained.
Continuous renal replacement therapy (CRRT) in intensive care unit (ICU) patients with acute renal failure (ARF) depends on sufficient anticoagulation of the extracorporeal circuit blood.
In tubing, catheters, extracorporeal circuits and other medical devices, the compounds will provide substantial cost-performance advantages over the anti-thrombogenic coatings currently applied to the inner surfaces of such devices, according to Bertram Lederer, senior vice president of Teknor Apex.
Coatings for cardiovascular devices: extracorporeal circuits
The EDAC[TM] QUANTIFIER is a tool for the surgical team to collect near real-time data on the quantity and volume of gaseous emboli at multiple locations in extracorporeal circuits during such procedures.
The EDAC[TM] QUANTIFIER can provide the surgical team with data on the quantity and volume of gaseous emboli at multiple locations in extracorporeal circuits during a procedure.
In tubing, catheters, extracorporeal circuits, and other medical devices, the compounds will provide substantial cost-performance advantages over the anti-clotting (anti-thrombogenic) coatings currently applied to the inner surfaces of such devices, according to Bertram M.
NASDAQ:THOR) announced today that its proprietary Surface Modifying Additive (SMA) technology has been shown to reduce platelet deposition and binding on the blood contacting surfaces of extracorporeal circuits in patients undergoing cardiopulmonary bypass (CPB).
As an initial step, Alexion will investigate the feasibility of using its proprietary complement inhibitors to halt platelet dysfunction, caused by the activation of the complement cascade, during platelet storage and circulation of blood through extracorporeal circuits.

Full browser ?